About Us

Eurolab is no ordinary oncology company.

SA’s largest generic oncology company focuses on new treatments and technologies for SA cancer patients

Eurolab is the largest generic oncology company in South Africa and one of the most innovative in cancer treatment, cancer management and cancer care. Headquartered in Johannesburg, South Africa, we provide treatment therapies and technologies for oncologists to offer their patients the best, the latest and the most affordable options for their cancer treatment.

  • Launch Date

    Launched in 2011, we are now establishing partnerships beyond SA’s borders into Africa and internationally

  • A Whole-Of-Cancer Approach

    Eurolab’s whole-of-cancer approach sets us apart in South Africa’s oncology sector, as we provide innovative yet affordable solutions, from diagnosis right through to treatment.  

  • Cancer Care Innovations

     The company is known for continually seeking new cancer care innovations in other parts of the world and bringing the best of these to South Africa. Today, patients in South Africa can access many of the same cancer technologies as patients in more developed nations. 

SA’s largest generic oncology company focuses on new treatments and technologies for SA cancer patients

Eurolab is the largest generic oncology company in South Africa and one of the most innovative in cancer treatment, cancer management and cancer care. Headquartered in Johannesburg, South Africa, we provide treatment therapies and technologies for oncologists to offer their patients the best, the latest and the most affordable options for their cancer treatment.

  • LAUNCH DATE

    Launched in 2011, we are now establishing partnerships beyond SA’s borders into Africa and internationally

  • A-WHOLE-OF-CANCER APPROACH

    Eurolab’s whole-of-cancer approach sets us apart in South Africa’s oncology sector, as we provide innovative yet affordable solutions, from diagnosis right through to treatment.

  • CANCER CARE INNOVATIONS

    The company is known for continually seeking new cancer care innovations in other parts of the world and bringing the best of these to South Africa. Today, patients in South Africa can access many of the same cancer technologies as patients in more developed nations.

Overview of our business

Quality and compliance are the cornerstones of our business. Eurolab drives quality across all its operations and, in South Africa, enjoys accreditation by the South African Health Products Regulatory Authority (SAHPRA) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). 

Our business was founded by two pioneers in South Africa’s pharmaceutical sector who recognised the pressing need to bring down the costs of cancer treatment. The Eurolab Group has grown steadily, continually expanding its whole-of-cancer offering to make more cancer treatment options available to more people at more affordable rates. 

Top proffesionals: make up our team which includes pharmacists, clinicians, haematologists, clinical pharmacologists, regulatory experts, health systems strengthening experts, marketers, ICT and financial experts, administrators, as well as leading oncologists.

Eurolab is proud to be a South African company, owned by South Africans, employing South Africans, and investing our profits back into the South African economy. We stay abreast of the latest clinical trials that test new treatment regimens for different kinds of cancer and enjoy strong relationships with academic and research institutions in South Africa and internationally.

Quality and safety are non-negotiable at Eurolab

Pharmacovigilance is central to Eurolab’s business. The company maintains a robust pharmacovigilance system as outlined by regulatory authorities to enhance patient care and safeguard patient safety.

“We handle reports of Adverse Events (AEs) concerning any of our products quickly and rigorously. Continuous monitoring of our products enables us to ensure the highest quality of oncology medicines for oncologists and their patients.” – Nicole Papert, Eurolab’s Pharmcovigilance Officer.

The pharmacovigilance team at Eurolab complies with the most up to date regulatory requirements and ensures their implementation across the business. They also remain abreast of the latest international trends, and train Eurolab staff so that current pharmacovigilance practices are maintained in all sectors of the business.

Security of supply of all Eurolab medicines is also a key focus area of the pharmacovigilance team.